IberiaBank’s Core Laboratories CLB Stock Holding History

IberiaBank’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,931	Closed	-$210K	–	156
2015 Q4	$210K	Sell	1,931 -367	-16%	-$42K	0.09%	155
2015 Q3	$229K	Sell	2,298 -705	-23%	-$76.7K	0.12%	138
2015 Q2	$342K	Sell	3,003 -50	-2%	-$6.06K	0.15%	116
2015 Q1	$319K	Buy	3,053 +915	+43%	+$97.5K	0.14%	124
2014 Q4	$257K	Buy	+2,138	New	+$281K	0.14%	138

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

IberiaBank's CLB Position: Q1 2016 in Review

IberiaBank sold out of Core Laboratories (CLB) in Q1 2016, closing a stake of 1,931 shares — an estimated $210K sold.

IberiaBank first reported a position in CLB in Q4 2014 and held it in 5 quarters. The position peaked at $342K in Q2 2015. 365 funds tracked by Wall St. Rank hold CLB as of Q1 2016.

IberiaBank reported no remaining Core Laboratories position as of Q1 2016 after selling out during the quarter.
IberiaBank sold 1,931 Core Laboratories shares in Q1 2016, an estimated $210K.
IberiaBank first reported a position in Core Laboratories in Q4 2014 and held it in 5 quarters.
IberiaBank's Core Laboratories position peaked at $342K in Q2 2015.
365 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2016.

Based on IberiaBank's 13F filing for Q1 2016, filed 15 Apr 2016.